128 related articles for article (PubMed ID: 9535390)
1. Whole blood screening test for factor V Leiden using a Russell viper venom time-based assay.
Akhtar MS; Blair AJ; King TC; Sweeney JD
Am J Clin Pathol; 1998 Apr; 109(4):387-91. PubMed ID: 9535390
[TBL] [Abstract][Full Text] [Related]
2. Comparison of an activated partial thromboplastin time with a Russell viper venom time test in screening for factor V(Leiden) (FVR506Q).
Sweeney JD; Blair AJ; King TC
Am J Clin Pathol; 1997 Jul; 108(1):74-7. PubMed ID: 9208981
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin, cardiac surgery, and factor V Leiden.
Sweeney JD; Blair AJ; Dupuis MP; King TC; Moulton AL
Transfusion; 1997; 37(11-12):1173-8. PubMed ID: 9426642
[TBL] [Abstract][Full Text] [Related]
4. A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutation.
Aboud MR; Ma DD
Br J Haematol; 1997 Jun; 97(4):798-803. PubMed ID: 9217178
[TBL] [Abstract][Full Text] [Related]
5. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
Ivey LM; Thom JY; Ivey JG; Baker RI
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.
Baig MA
Indian J Pathol Microbiol; 2020; 63(2):247-250. PubMed ID: 32317524
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Russell viper venom-based and activated partial thromboplastin time-based screening assays for resistance to activated protein C.
Herskovits AZ; Lemire SJ; Longtine J; Dorfman DM
Am J Clin Pathol; 2008 Nov; 130(5):796-804. PubMed ID: 18854273
[TBL] [Abstract][Full Text] [Related]
8. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
Favaloro EJ; Mirochnik O; McDonald D
Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
[TBL] [Abstract][Full Text] [Related]
9. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.
Zehnder JL; Benson RC
Am J Clin Pathol; 1996 Jul; 106(1):107-11. PubMed ID: 8701918
[TBL] [Abstract][Full Text] [Related]
11. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
12. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C.
Kraus M; Zander N; Fickenscher K
Thromb Res; 1995 Nov; 80(3):255-64. PubMed ID: 8578552
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
14. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
[TBL] [Abstract][Full Text] [Related]
15. The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance.
Sayinalp N; Haznedaroğlu IC; Aksu S; Büyükaşik Y; Göker H; Parlak H; Ozcebe OI; Kirazli S; Dündar SV; Gürgey A
Clin Appl Thromb Hemost; 2004 Jul; 10(3):265-70. PubMed ID: 15247984
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
Graf LL; Welsh CH; Qamar Z; Marlar RA
Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
[TBL] [Abstract][Full Text] [Related]
17. The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation.
Quehenberger P; Handler S; Mannhalter C; Kyrle PA; Speiser W
Thromb Res; 1999 Oct; 96(2):125-33. PubMed ID: 10574590
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance.
Liebman HA; Sutherland D; Bacon R; McGehee W
Br J Haematol; 1996 Dec; 95(3):550-3. PubMed ID: 8943900
[TBL] [Abstract][Full Text] [Related]
19. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
Svensson PJ; Zöller B; Dahlbäck B
Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
